Human recombinant soluble ACE2 in severe COVID-19
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bourgonje, 2020, Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19), J Pathol, 251, 228, 10.1002/path.5471
Zhang, 2020, Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target, Intensive Care Med, 46, 586, 10.1007/s00134-020-05985-9
Monteil, 2020, Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2, Cell, 181, 905, 10.1016/j.cell.2020.04.004
Kuba, 2005, A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury, Nat Med, 11, 875, 10.1038/nm1267
Crackower, 2002, Angiotensin-converting enzyme 2 is an essential regulator of heart function, Nature, 417, 822, 10.1038/nature00786
Wong, 2007, Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury, Am J Pathol, 171, 438, 10.2353/ajpath.2007.060977
Haschke, 2013, Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects, Clin Pharmacokinet, 52, 783, 10.1007/s40262-013-0072-7
Khan, 2017, A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome, Crit Care, 21, 234, 10.1186/s13054-017-1823-x
Zhang, 2020, Viral and host factors related to the clinical outcome of COVID-19, Nature, 583, 437, 10.1038/s41586-020-2355-0
Jabaudon, 2018, Plasma sRAGE is independently associated with increased mortality in ARDS: a meta-analysis of individual patient data, Intensive Care Med, 44, 1388, 10.1007/s00134-018-5327-1
Lopez-Cano, 2017, Serum surfactant protein D as a biomarker for measuring lung involvement in obese patients with type 2 diabetes, J Clin Endocrinol Metab, 102, 4109, 10.1210/jc.2017-00913
Walls, 2020, Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein, Cell, 181, 281, 10.1016/j.cell.2020.02.058
Okba, 2020, Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease 2019 patients, Emerg Infect Dis, 26, 1478, 10.3201/eid2607.200841
Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 270, 10.1038/s41586-020-2012-7
Imai, 2005, Angiotensin-converting enzyme 2 protects from severe acute lung failure, Nature, 436, 112, 10.1038/nature03712
Zou, 2014, Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections, Nat Commun, 5, 10.1038/ncomms4594
Yang, 2014, Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury, Sci Rep, 4, 10.1038/srep07027
Huang, 2014, Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients, Nat Commun, 5, 10.1038/ncomms4595
Liu, 2020, Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury, Sci China Life Sci, 63, 364, 10.1007/s11427-020-1643-8
Gheblawi, 2020, Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2, Circ Res, 126, 1456, 10.1161/CIRCRESAHA.120.317015
Senchenkova, 2010, Angiotensin II-mediated microvascular thrombosis, Hypertension, 56, 1089, 10.1161/HYPERTENSIONAHA.110.158220
Han, 1999, Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors, Circ Res, 84, 695, 10.1161/01.RES.84.6.695
Corey, 2020, A strategic approach to COVID-19 vaccine R&D, Science, 368, 948, 10.1126/science.abc5312